Disease: lung adenocarcinoma (PMID:25089627)
Dysfunction type: expression
Description: LOC100132354 and RPLP0P2 exhibited the most significantly changed expression in our analysis of 100 pairs of lung adenocarcinoma and normal lung tissue samples. The expression of LOC100132354 was significantly higher in lung adenocarcinoma than in the adjacent tissues, while the expression of RPLP0P2 was significantly lower in lung adenocarcinoma than in the adjacent tissues.
Function Mechanism: NA (PMID:25089627)
Biological Process: pathogenic process